iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Leishmaniasis

Leishmaniasis

Overview of cutaneous and visceral leishmaniasis.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Infectious DiseasesTravel MedicineDermatology

Clinical Guidelines

ASTMH/IDSA Clinical Practice Guidelines for the Diagnosis and Management of Leishmaniasis
National
Guideline for the treatment of Leishmaniasis in the Americas
National
WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia
National
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
Local
Guideline for the Treatment of Leishmaniasis in the Americas
Local
Guideline for the treatment of Leishmaniasis in the Americas. Second edition
Local
WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients
Local

Recent iatroX Q&As

  • What are the key clinical features that differentiate cutaneous leishmaniasis from other skin lesions?Updated: 8/22/2025
  • What are the recommended first-line treatments for cutaneous leishmaniasis in adults?Updated: 8/22/2025
  • What laboratory investigations are essential for confirming a diagnosis of leishmaniasis in primary care?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play